Omeros Corp (OMER) awards CEO 1,000,000 stock options with 2036 expiry
Rhea-AI Filing Summary
Omeros Corporation reported that Chairman, CEO & President Gregory A. Demopulos received a grant of 1,000,000 stock options on July 22, 2026. The options have an exercise price of $9.84 per share, expire on July 22, 2036, and are exercisable into an equal number of common shares.
According to the vesting schedule, one-third of the options vest and become exercisable on August 1, 2027, with the remaining options vesting in 32 equal monthly installments on the first day of each month thereafter. Following this grant, he directly holds stock options for 1,000,000 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Demopulos Gregory A MD
Role
Chairman, CEO & President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 1,000,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 1,000,000 shares (Direct)
Footnotes (1)
- F1. One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter.
Key Figures
Stock options granted: 1,000,000 shares
Exercise price: $9.8400 per share
Expiration date: 2036-07-22
+3 more
6 metrics
Stock options granted
1,000,000 shares
Stock Option (right to buy) granted to Gregory A. Demopulos on 2026-07-22
Exercise price
$9.8400 per share
Conversion or exercise price of the granted stock options
Expiration date
2036-07-22
Expiration of stock options granted to Gregory A. Demopulos
Underlying common shares
1,000,000 shares
Common Stock underlying the granted stock options
Vesting start date
August 1, 2027
One-third of the options vest and become exercisable on this date
Remaining vesting installments
32 monthly installments
Remaining options vest in 32 equal monthly installments thereafter
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date
4 terms
Stock Option (right to buy) financial
"Security title reported as Stock Option (right to buy)"
exercise price financial
"Conversion or exercise price reported as $9.8400 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"One-third of the total number of shares subject to the option will vest"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"Expiration date of the option is 2036-07-22"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Omeros (OMER) disclose about Gregory Demopulos's new stock options?
Omeros disclosed that Gregory A. Demopulos received 1,000,000 stock options for common shares at an $9.84 exercise price, expiring on July 22, 2036. This is a grant or award, not an open-market purchase, and is reported as directly owned.
What is the exercise price and expiration date of the new OMER CEO options?
The granted options carry an exercise price of $9.84 per share and an expiration date of July 22, 2036. They are classified as "Stock Option (right to buy)" and are exercisable into an equal number of Omeros common shares.
How do the granted OMER stock options vest for Gregory Demopulos?
The filing states that one-third of the total options will vest and become exercisable on August 1, 2027. The remaining options will then vest in 32 equal monthly installments on the first day of each month after that date.
How many options does Gregory Demopulos hold after this OMER grant?
After the reported transaction, Gregory A. Demopulos directly holds stock options covering 1,000,000 shares of Omeros common stock. This total reflects the newly granted option position as reported in the Form 4's post-transaction holdings field.
Was the OMER CEO's option grant reported under a Rule 10b5-1 trading plan?
The Form 4 checkbox for Rule 10b5-1 plans is not marked as an affirmative plan transaction, indicating the grant is not identified as made pursuant to a Rule 10b5-1 trading plan in this filing.